China National Accord Medicines reports profit decline amid revenue dip

China National Accord Medicines Corporation reported operating revenue of 3.68 billion yuan for the first half of 2025, down 2.62% year-on-year. Net profit attributable to shareholders fell 10.43% to 66.59 million yuan.

The distribution segment's profit dropped 7.82% due to increased bad debt provisions, while the retail segment's net profit surged 215.81% despite a 6.46% revenue decline.